 NEW YORK--BUSINESS WIRE--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Millendo Therapeutics, Inc. NASDAQ: MLND and Tempest Therapeutics, Inc. is fair to Millendo shareholders. Upon completion of the merger, Millendo shareholders are expected to own approximately 18.5 of the combined company while pre-merger Tempest stockholders will own approximately 81.5 of the combined company. Halper Sadeh encourages Millendo shareholders to click here to 